Show Summary Details
Page of

Haemodialysis 

Haemodialysis

Chapter:
Haemodialysis
Author(s):

Ken Farrington

and Roger Greenwood

DOI:
10.1093/med/9780199204854.003.210701_update_001

Update:

Timing of initiation of dialysis—the IDEAL (Initiating Dialysis Early And Late) study revealed that planned early initiation was not associated with an improvement in survival or clinical outcomes.

Frequency of dialysis—the randomized Frequent Hemodialysis Network Trial showed the benefits of 6 times weekly versus conventional 3 times weekly sessions.

Management of heparin-induced thrombocytopenia—recommendations for the use of heparinoid or argatroban.

Management of hypertension in dialysis patients—discussion of the general move for guidelines to become less prescriptive, recognizing risks of overtreatment as well as of undertreatment.

Management of hyperlipidaemia in dialysis patients—discussion of the findings of the SHARP trial, which showed that lowering LDL cholesterol with simvastatin plus ezetimibe reduced major atherosclerotic events, but did not have significant effects on cardiovascular or total mortality.

Updated on 25 May 2011. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 22 June 2017

Over the past four decades, maintenance haemodialysis has proved to be a highly successful treatment for patients with endstage renal disease. In the developed world, the haemodialysis population continues to increase and is becoming more elderly and dependent. However, despite considerable advances in haemodialysis technology and other significant improvements, such as those in renal anaemia management, the long-term clinical outcomes for patients remain much less good than those of other people with comparable characteristics but without renal failure....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.